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Summary
Background: Mutated copper, zinc-containing superoxide
dismutase (SOD1) may self-aggregate, an event that could
also be an initial cause of motor neuron malfunction leading
to disease onset. The effects of human mutated SOD1 pro-
tein from the blood of familial amyotrophic lateral sclerosis
(FALS) patients bearing Leu144Phe (L144F) mutation were
compared to wild-type (WT) human SOD1 derived from
healthy examinees, for enzymatic activity and the effects on
isometric contractions of non-vascular smooth muscle.
Methods: We isolated WT and L144F SOD1 enzymes from
eight patients with FALS, L144F mutation in exon 5 and
eight healthy controls. We then investigated SOD1 activities
in the obtained samples by the adrenaline method and  pro-
filed them electrophoretically. Finally, we applied WT and
L144F SOD1 on the isolated rat uterus. 
Results: L144F SOD1 showed lower superoxide-dismutating
activity compared to WT human SOD1. We found that, in
contrast to WT human SOD1, mutated L144F does not
induce smooth muscle relaxation. 
Conclusions: Our data suggest that the lack of relaxation of
muscle tonus in the presence of mutated SOD1 may have
pathogenic feedback effects in FALS.
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Kratak sadr`aj
Uvod: Mutirana bakar, cink superoksid-dizmutaza (SOD1)
mo`e da pravi agregate, {to predstavlja po~etni uzrok o{te -
}enja motornog neurona mo`e da izazove nastanak bolesti.
U ovom radu su pokazani efekti hu mane bakar, cink super-
oksid dizmutaze iz krvi pacijenata obolelih od familijarne
amiot ro fi~ne lateralne skleroze (FALS) sa Leu144Phe
(L144F) mutacijom i normalne (wild-type – WT) humane
SOD1, iz krvi zdravih kontrola, na glatkom mi{i}u. 
Metode: Izolovali smo WT i L144F SOD1 enzime kod osam
odabranih FALS pacijenata sa L144F mutacijom na egzonu
5 i pet zdravih kontrola. Dalje smo ispitivali aktiv nost SOD1
u dobijenim uzorcima adrenalinskom meto dom i elektro-
foretski ih profilisali. Kona~no, izolovanu WT i L144F
SOD1 aplicirali smo na izolovani uterus pacova. 
Rezultati: Aktivnost L144F SOD1 je statisti~ki zna ~ajno
manja (p<0,05) u pore|enju sa aktivnosti WT SOD1 zdra -
vih kontrola. L144F ne izaziva relaksaciju glatkog mi{i}a,
kao {to je to slu~aj sa WT SOD1.
Zaklju~ak: Na{i rezultati pokazuju da izostanak relaksacije
mi{i}nog tonusa u prisustvu mutirane SOD1 mo`e imati
{tetni povratni efekat kod FALS pacije nata. 
Klju~ne re~i: FALS, L144F SOD1, WT SOD1, relaksa -
cija
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Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal pro-
gressive disorder clinically characterized by muscle
wasting and weakness and pathologically character-
ized by the relatively selective degeneration of upper
motor neurons in the motor cortex and lower motor
neurons in the brain stem and spinal cord (1). The
discovery of a mutation in the SOD1 gene prompted
the hypothesis that oxidative stress may play a role in
the pathogenesis of ALS (2). About 10% of ALS cases
are familial ALS (FALS), which has been associated
with more than 150 different point mutations on
superoxide dismutase-1 (SOD1) locus (3). Wild-type
and mutated SOD1 (WT SOD) can exhibit additional
enzymatic activities, including superoxide reductase
and/or oxidase activities, may self-aggregate, an
event that could also be an initial cause of motor neu-
ron malfunction leading to disease onset (4). An
increasing body of evidence implies that SOD1 muta-
tion may show ALS-related effects by affecting mus-
cles and neuromuscular junction. In line with recent
evidence of SOD1 secretion in diverse cell lines,
Turner et al. (5) have proposed that mutant SOD1
engages in ALS pathogenesis by modulating different
secretory pathways. In other words, mutated SOD1
may be involved in extra-cellular events directly affect-
ing other cells, as previously shown on microglia (6).
Growing evidence in support of a toxic channel
hypothesis also for Alzheimer’s disease and other
neurodegenerative diseases lends credence to a com-
mon disease mechanism in protein misfolding dis-
eases (7, 8). Consistent with this scenario, altered lev-
els of intracellular calcium (Ca2+) are reported to
contribute to the motor neuron degeneration and
mitochondrial dysfunction associated with ALS
(9–12). Morikawa et al. (13) showed that SOD1
beside dismutation had some other functions (13).
WT SOD1 could provoke endothelium-dependent
relaxation, implying a role of extracellular SOD in
smooth muscle function. 
This prompted us to compare the effects of WT
SOD1 isolated from the blood of healthy volunteers
with mutated L144F human SOD1 obtained from the
blood of FALS patients on isometric contractions of
uteri taken from healthy virgin rats. The isolated
uterus is a very suitable experimental model for this
kind of study due to the presence of complex signal
transduction systems, most of up-to-date identified
ion channels and the redox sensitivity of this non-vas-
cular smooth muscle (14). 
Material and Methods 
Material
In this paper, we have selected patients with
FALS, L144F mutation in exon 5, because this is the
most common SOD1 mutation so far registered in
Serbia. Eight patients diagnosed for L144F FALS were
informed that their blood was to be used for both rou-
tine medical analyses and our laboratory research.
Patient recruitment, counseling, sample collection
and handling were conducted according to interna-
tionally recognized ethical standards (The Helsinki
Declaration of 1964, as revised in 1975, 1983, and
1989). Institutional approval for the study was grant-
ed by The Clinic Ethics Committee which followed
international guidelines. All participants provided
their written consent.
In all the examined FALS patients, molecular
genetic analyses were performed according to the fol-
lowing procedures: DNA samples of FALS patients
were collected at the PCR Center, Faculty of Biology,
Uni ver sity of Belgrade. Coding regions and exon-in -
tron boundaries of SOD1 (5 exons) genes were am -
pli fied and analyzed using the Big Dye terminator
v.1.1 sequencing kit on an ABI 3130 genetic analy zer.
Sequence of the primers and amplification conditions
are available upon request. In our FALS patients with
L144F SOD1 mutation, direct sequencing analysis of
all five exons of SOD 1 gene revealed presence of
heterozygous c.435G>C (L144F) point mutation in
exon5.
Isolation of wild-type and mutated SOD1 
We used leftovers of blood samples collected for
standard biochemical analyses from 8 FALS patients
(q/q) with L144F mutation as well as the blood from
8 healthy controls for isolation of SOD 1. Heparinized
blood samples were centrifuged at 3000 rpm for 15
min at 4 °C, and the separated erythrocytes were
washed three times with 0.9% NaCl, and then lyzed
by adding 3 mL of ice-cold distilled water. Proteins in
the lysates were denatured by heat (60 °C) with con-
stant stirring (SOD1 is stable up to 70 °C). Residue
was separated by centrifugation at 5000 rpm at 5 °C.
All other proteins and hemoglobin (Hb) residues were
removed by the repeated Tsuchihashi procedure (15).
The activity of SOD1 and the purity of preparations
were determined by electrophoresis, showing no
other protein band except for SOD1 bands. 
Biochemical procedures 
All chemicals were purchased from Sigma-
Aldrich (St. Louis, MO, USA). The activity of SOD1
was assayed using superoxide anion radical-mediated
oxidation of epinephrine to adrenochrome at pH 10.2
(16), and expressed in U/g of Hb. Hb was estimated
by the method of Drabkin and Austin (17). Native
polyacrylamide gel electrophoresis (PAGE) was per-
formed according to Laemmli (18), using 12% acry-
lamide. SOD was diluted to 2 mg proteins/mL of a
solution containing 12% glycerol, 0.5 mmol/L Tris-
HCl (pH 6.8), and 0.2 EDTA before loading 50 mL
wells. For detection of proteins, gels were stained with
0.03% Comassie Brilliant Blue R250. SOD bands were
visualized by the activity-staining procedure described
by Beauchamp and Fridovich (19). The gel was first
soaked in 25 mL of 1.23 mmol/L NBT for 15 min,
briefly washed, then soaked in the dark in 30 mL of 1
mol/L potassium phosphate buffer (pH 7.0) contain-
ing 20 mmol/L TEMED and 2.8 × 10–2 mmol/L ribo -
flavin for another 15 min. The gel was briefly washed
again, and then illuminated on a light box with a light
intensity of 30 mEm–2s–1 (measured by LI-COR LI
1000) for 15 min to initiate the photochemical reac-
tion. 
Uterine contraction experimental system 
Uteri were isolated from virgin Wistar rats
(200–250 g) in estrous determined by examination of
daily vaginal lavage (20). The uterine horns were rap-
idly excised and carefully cleaned of surrounding con-
nective tissue and mounted vertically in an organ bath
containing De Jalon solution, aerated with 95% oxy-
gen and 5% carbon dioxide at 37 °C. The preload of
the preparation was about 1 g. Experiments were per-
formed on Ca2+ induced active uteri and treated with
SODs. Isometric contractions were recorded by iso-
metric force transducer (Experimetria, Budapest,
Hungary). Uteri were exposed to SOD1 showing total
activity of ∼ 200 U. Reduction of peak represents
relaxation.
Statistical analysis 
All experiments using human SOD1 were re -
peated 8 times. Statistical difference was determined
by the means of the non-parametric two-tailed Mann-
Whitney test using Statistica 6.0 (StatSoft Inc, Tulsa,
OK, USA). Results are presented as means ± S.D.
and were taken to be statistically different if p<0.05. 
Results and Discussion
The effects of SODs on the Ca2+ induced acti-
vation of uteri are presented in Figure 1. Human WT
SOD1 had a relaxing effect on the isolated smooth
muscle, while human L144F mutated SOD1 did not
show any effects on isolated smooth muscle contrac-
tions. 
L144F SOD1 showed significantly (p<0.05)
lower enzyme activity compared to WT SOD1. The
activity of human WT SOD1 isolated from the ery-
throcytes was 2791±22 U/g of Hb, while the activity
of human L144F SOD1 isolated from the erythro-
cytes of FALS patient was 1342±37 U/g of Hb. The
decreased activities of L144F SOD1 biochemical
assay were verified by the results of electrophoresis,
as shown in Figure 2. Although the same amount of
proteins was loaded on the gels (Figure 2 left), visu a -
li zed L144F SOD 1, according to the resulting bands
(Figure 2 right), showed decreasing SOD 1 activity. 
We propose that the changes in the structure of
SOD1 mutated proteins force it to bind the muscle
surface, leading to increased Ca2+ permeability and
thus eliminating the relaxation effect which was
observed for WT SOD1. Similar to the finding of Miler
et al, that mutated SOD1 induce channel-like ionic
conductance of pore-like structures they form, the
cellular Ca2+ uptake and cell membrane depolariza-
tion is affected by the mutant SOD1. The lack of
relaxing effects in the presence of L144F SOD1 com-
pared to WT SOD1 may have negative feedback
effects on motor neurons. It has been shown that
mutations may cause SOD1 to have an increased
propensity to misfold or aggregate (21). Pertinent to
this, Zhong et al. (22) have proposed that the failure
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Figure 1 Characteristic trace of Ca2+ induced uterine con-
tractions monitoring. WT SOD1 (200 U);  – The points of
SOD1 and L144F SOD1 application (200 U).
Figure 2 Non-reducing PAGE of SOD1 electrophoresis.
Left: proteins stained with Coomassie blue; WT SOD1 and
L144F SOD1; right: staining for SOD activity; WT SOD1 and
L144F SOD1. 
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of mutated SOD1 to initiate smooth muscle relax-
ation may be involved in ALS pathogenesis.
Recent findings link abnormalities in ubiquilin 2
in juvenile and adult-onset ALS to defects in the pro-
tein degradation pathway, abnormal protein aggrega-
tion and neurodegeneration, indicating a common
pathogenic mechanism that can be exploited for ther-
apeutic intervention (23, 24). WT and mutant
(G41R, G93A, or N139K) human SOD1 have been
expres sed in motor neurons of dissociated cultures of
mu rine spinal cord by intranuclear microinjection of
plasmid expression vector. Both the general antago-
nist of AMPA/kainate receptors (CNQX) and specific
antagonist of Ca2+-permeable AMPA receptors (joro
spider toxin) have reduced formation of SOD1 pro-
teinaceous aggregates and prevented death of motor
neurons expressing SOD1 mutants. Partial protection
has been obtained by treatment with nifedipine,
implicating Ca2+ entry through voltage-gated Ca2+
channels, as well as glutamate receptors in potentiat-
ing the toxicity of mutant SOD1 in motor neurons.
Dramatic neuroprotection has been obtained by
coexpressing the Ca2+-binding protein calbindin-
D28k, but not by increasing intracellular glutathione
levels or treatment with a free radical spin trap agent,
N-tert-butyl-alpha-phenylnitrone. Therefore, the gen-
eralized oxidative stress could have contributed to the
death of motor neurons expressing the mutant SOD1
only in a minor way. These studies have demonstrat-
ed that the toxicity of these mutants is Ca2+-depend-
ent and they provide direct evidence that Ca2+ entry
during neurotransmission, coupled with deficiency of
cytosolic Ca2+-binding proteins, is a major factor in
the preferential vulnerability of motor neurons to dis-
ease (25).
It should be stressed that neuromuscular junc-
tions are the first to be lost in ALS, followed by the
loss of ventral root axons, while motor neurons are
the last to die (26). Pertinent to this, the »dying back«
pattern has been proposed (27). Our results imply
that mutant SOD1 may provoke mechanical damage
to the muscles and neuromuscular junctions indirect-
ly, by being unable to perform the relaxing function of
the WT. Such unregulated activity of the muscles may
have pathogenic feedback effects on neurons and
potentially an important role in FALS initiation. 
Acknowledgements. This work was supported
by grants from the Ministry of Education, Science and
Technological Development of the Republic of Serbia
(Grants No.173014 and 175083). 
Conflict of interest statement
The authors stated that there are no conflicts of
interest regarding the publication of this article. 
References
1. Nikoli}-Koki} A, Stevi} Z, Blagojevi} D, Davidovi} D,
Jones DR, Spasi} MB. Alterations in anti-oxidative
defense enzymes in erythrocytes from SALS and FALS
patients. Clin Chem Lab Med 2006; 44: 589–93.
2. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp
P, et al. Mutations in Cu/Zn superoxide dismutase gene
are associated with familial amyotrophic lateral sclerosis.
Nature 1993; 362: 59–62.
3. Siddique N, Siddique T. Genetics of amyotrophic lateral
sclerosis. Phys Med Rehabil Clin N Am 2008; 19:
429–39. 
4. Kiernan MC, Vu~i} S, Cheah BC, Turner MR, Eisen A,
Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet
2011; 377: 942–55.
5. Turner BJ, Atkin JD, Farg MA, WeiZang D, Rembach A,
Lopes EC, et al. Impaired extracellular secretion of
mutant superoxide dismutase 1 associates with neurotox-
icity in familial amyotrophic lateral sclerosis. J Neurosci
2005; 25: 108–17.
6. Yim MB, Kang JH, Yim HS, Kwak HS, Chock PB,
Stadtman ER. A gain-of-function of an amyotrophic lat-
eral sclerosis-associated Cu, Zn-superoxide dismutase
mutant: An enhancement of free radical formation due
to a decrease in Km for hydrogen peroxide. Proc Natl
Acad Sci USA 1996; 93: 5709–14.
7. Jang H, Arce FT, Ramachandran S, Capone R, Azimova
R, Kagan BL, et al. Truncated beta-amyloid peptide
channels provide an alternative mechanism for
Alzheimer's Disease and Down syndrome. Proc Natl
Acad Sci USA 2010; 107: 6538–43.
8. Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione
B, et al. Amyloid ion channels: a common structural link
for proteinmisfolding disease. Proc Natl Acad Sci USA
2005; 102: 10427–32.
9. Grosskreutz J, Haastert K, Dewil M, Van Damme P,
Callewaert G, Robberecht W, et al. Role of mitochondria
in kainate-induced fast Ca2+ transients in cultured spinal
motor neurons. Cell Calcium 2007; 42: 59–69.
10. Ionov ID. Survey of ALS-associated factors potentially
promoting Ca2+ overload of motor neurons. Amyo troph
Lateral Scler 2007; 8: 260–5.
11. Kuwabara S, Kanai K. Altered axonal ion channel func-
tion in amyotrophic lateral sclerosis. Brain Nerve 2007;
59: 1109–15.
12. Pieri M, Albo F, Gaetti C, Spalloni A, Bengtson CP,
Longone P, et al. Altered excitability of motor neurons in
a transgenic mouse model of familial amyotrophic later-
al sclerosis. Neurosci Lett 2003; 351: 153–6.
13. Morikawa K, Shimokawa H, Matoba T, Kubota H, Akaike
T, Talukder MA, et al. Pivotal role of Cu, Zn-superoxide
dismutase in endothelium-dependent hyperpolarization.
J Clin Invest 2003; 112: 1871–9.
14. Appiah I, Milovanovi} S, Radoji~i} R, Nikoli}-Koki} A,
Ore{~anin-Du{i} Z, Slavi} M, et al. Hydrogen peroxide
affects rat uterine contractile activity and endogenous
antioxidative defence. Br J Pharmacol 2009; 158:
1932–41. 
15. Tsuchihashi M. Zur Kenntnis der Blutkatalase. Biochem
Z 1923; 140: 65–74.
16. Misra HP, Fridovich I. The role of superoxide anion in the
autoxidation of epinephrine and a simple assay for super-
oxide dismutase. J Biol Chem 1972; 247: 3170–5. 
17. Drabkin DL, Austin JH. Spectrophotometric studies. II
Preparations from washed blood cells: nitric oxide hemo-
globin and sulfhemoglobin. J Biol Chem 1935; 112:
51–5.
18. Laemmli UK. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 1970;
7: 680–5.
19. Beauchamp C, Fridovich I. Superoxide dismutase: im -
proved assays and an assay applicable to acrylamide
gels. Anal Biochem 1971; 44: 276–87. 
20. Marcondes FK, Bianchi FI, Tanno AP. Determination of
the estrous cycle phases of rats: some helpful considera-
tions. Braz J Biol 2002; 62: 609–14.
21. Stathopulos PB, Rumfeldt JA, Karbassi F, Siddall CA,
Lepock JR, Meiering EM. Calorimetric analysis of thermo-
dynamic stability and aggregation for apo and holo amy-
otrophic lateral sclerosis-associated Gly-93 mutants of
superoxide dismutase. J Biol Chem 2006; 281:
6184–93. 
22. Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y,
O’Banion MK, et al. ALS-causing SOD1mutants gener-
ate vascular changes prior to motor neuron degenera-
tion. Nat Neurosci 2008; 4: 420–2.
23. Brotherton T, Polak M, Kelly C, Birve A, Andersen P,
Marklund SL, Glass JD. A novel ALS SOD1 C6S mutation
with implications for aggregation related toxicity and
genetic counseling. Amyotroph Lateral Scler 2011; 12:
215–19.
24.  Simsek K, Yildirim AO, Demirbas S, et. al. Response of
rate erythrocyte  oxidative stress markers to repetitive
hyperbaric oxygen exposures up to 40 daily sessions. J
Med Biochem 2013; 32: 32–8.
25. Roy J, Minotti S, Dong L, Figlewicz DA, Durham HD.
Glutamate potentiates the toxicity of mutant Cu/Zn-
superoxide dismutase in motor neurons by postsynaptic
calcium-dependent mechanisms. J Neurosci 1998; 18:
9673–84.
26. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M,
Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis
is a distal axonopathy: evidence in mice and man. Exp
Neurol 2004; 185: 232–40.
27. Dadon-Nachum M, Melamed E, Offen D. The »dying-
back« phenomenon of motor neurons in ALS. J Mol
Neurosci 2011; 43: 470–7.
J Med Biochem 2013; 32 (4) 379
Received: June 6, 2013
Accepted: June 29, 2013
